
New COVID Variant Symptoms: What to Know About Cicada
If you’ve been hearing whispers about a “Cicada” COVID variant and wondering whether your scratchy throat means something different this time around, you’re not alone. Health officials in Ireland recently flagged a surge in cases, and the BA.3.2 strain has now shown up in at least 23 countries.
Main symptoms: sore throat, cough, fatigue, fever, headaches, congestion ·
Unusual symptoms: sneezing, nausea, vomiting, diarrhea ·
Detected in: 23 countries including Ireland ·
Recent surge: Irish cases reported March 2026 ·
Vaccine efficacy: may be less effective
Quick snapshot
- Core symptoms match prior variants per HSE/NHS (Stony Brook Medicine)
- Presence in Ireland confirmed (CIDRAP)
- No evidence of more severe disease than recent strains (Stony Brook Medicine)
- Continued global surveillance by WHO and CDC
- Monitoring for changes in severity or transmission patterns
The following table summarizes key details about the BA.3.2 (Cicada) variant including symptoms, origin, and prevalence data.
| Detail | Information |
|---|---|
| Variant name | BA 3.2 (Cicada) |
| Primary symptoms | fever, cough, fatigue |
| Additional symptoms | sore throat, congestion, sneezing |
| Origin reports | 23 countries, Ireland surge |
| First identified | South Africa, November 22, 2024 |
| Global prevalence | approximately 8% |
| US prevalence | 0.19% of 2,579 sequences |
| Recovery time | 3–7 days symptom improvement; 1–2 weeks full recovery |
What are the main symptoms of the newest COVID?
The Cicada variant does not cause new or unusual symptoms compared to other Omicron COVID-19 variants, according to Stony Brook Medicine. Most people infected with BA.3.2 experience symptoms that overlap substantially with what we’ve seen in previous waves.
Common symptoms
The most frequently reported symptoms include cough, fatigue or low energy, fever, and body aches. These match the classic COVID presentation that most people recognize by now. Additional BA.3.2 symptoms may include sore throat, runny nose or congestion, headache, shortness of breath, nausea or reduced appetite, and brain fog, according to Stony Brook Medicine. Loss of taste or smell is now less common with BA.3.2 but still possible.
Unusual symptoms
Some patients have reported gastrointestinal symptoms like nausea, vomiting, and diarrhea — symptoms that can sometimes be mistaken for a stomach bug. Sneezing has also been noted more frequently than in some earlier variants, which can lead people to dismiss their illness as seasonal allergies.
If you have a combination of sore throat, cough, and fatigue — especially if you’ve been exposed to someone with confirmed COVID — there’s a reasonable chance you’re dealing with the Cicada variant. Testing confirms it.
The implication is that symptom recognition alone isn’t sufficient; testing remains the definitive way to identify BA.3.2.
How long does the latest COVID usually last?
For most individuals infected with BA.3.2, symptoms improve within 3–7 days, according to Apollo Hospitals. Full recovery typically occurs within 1–2 weeks. This timeline aligns closely with what we’ve seen in previous Omicron subvariants.
Duration of symptoms
The acute phase — when you’re most likely to feel miserable — usually peaks around days 2-4. After that, most people start feeling noticeably better. Fatigue can linger a bit longer, and some people report that a dry cough persists for another week or so after other symptoms resolve.
Recovery timeline
The CDC and NHS guidance suggests that most healthy adults recover fully within two weeks. Older adults, immunocompromised individuals, or those with underlying health conditions may take longer and should stay in close contact with their healthcare provider.
If symptoms worsen significantly after initially improving — particularly shortness of breath or chest pain — that’s a signal to seek medical attention promptly, regardless of how many days it’s been.
What this means is that most people recover without complications, but monitoring for deterioration remains essential especially for at-risk groups.
How long are you contagious with the newest strain of COVID?
The contagious period for BA.3.2 follows the same general pattern as other Omicron variants. You are most contagious in the days immediately before and after symptom onset. Most people stop being contagious about 10 days after symptoms begin, provided they’ve been fever-free for at least 24 hours without medication and symptoms are improving.
Contagious period
Current guidance from health authorities indicates that isolation should continue for at least 5 full days after symptom onset, with masking for 10 days as a precaution. This applies whether you have the original COVID strain or the Cicada variant.
Testing and isolation
Rapid antigen tests are useful for determining if you’re still actively shedding virus. If you have access to rapid tests, two consecutive negative results taken 24 hours apart can help confirm you’re no longer contagious. PCR tests can remain positive longer and are not the best indicator of contagiousness.
The pattern here mirrors earlier variants, meaning existing isolation guidance applies without modification.
Is there a new strain of COVID going around?
Yes. The BA.3.2 variant — nicknamed the “Cicada” variant — has been detected in at least 23 countries as of February 11, 2026, according to CIDRAP. The variant was first identified in South Africa on November 22, 2024, according to CDC MMWR. Recent reports indicate a surge in Irish cases in March 2026.
Cicada variant details
BA.3.2 is a sublineage of the Omicron variant descended from an ancestral version of BA.3 that had not circulated since early 2022, according to Wikipedia. It has approximately 70–75 substitutions and deletions in the spike protein gene sequence relative to JN.1 and LP.8.1, according to CDC MMWR. The World Health Organization declared BA.3.2 a variant under monitoring (VUM) on December 5, 2025.
Spread in Ireland
Health officials in Ireland have reported a notable surge in Cicada variant cases since March 2026. The variant was detected in 25 US states via wastewater monitoring, and globally accounts for about 8% of variants per the WHO, according to New York Presbyterian. From November 2025 to January 2026, weekly BA.3.2 detections increased to about 30% of sequences in Denmark, Germany, and the Netherlands.
BA.3.2 exhibits antibody escape characteristics that likely increase infection or reinfection risk, though current vaccines still appear to protect against severe disease, according to Global Virus Network.
The catch is that even if vaccines become less effective at preventing infection, their role in reducing severe outcomes remains critical.
How can I tell if I have COVID or a cold?
Distinguishing between COVID and a common cold can be tricky because they share many symptoms. The key difference often lies in the specific combination and intensity of symptoms, plus any potential exposure to confirmed COVID cases.
Key differences
COVID is more likely to cause fever, body aches, and fatigue that feels more severe than a typical cold. A cold typically starts with a sore throat and runny nose, while COVID may include shortness of breath or chest discomfort as prominent features. Loss of taste or smell, while less common now, still leans more toward COVID.
When to test
If you have any respiratory symptoms and either have been around someone with confirmed COVID or live in an area with high transmission, testing is advisable. Rapid antigen tests are widely available and can give you a quick result within 15 minutes.
BA.3.2 Timeline
The timeline below tracks key milestones in the BA.3.2 variant’s emergence and global spread.
| Date | Event |
|---|---|
| November 22, 2024 | First identified in South Africa |
| December 5, 2025 | WHO declares BA.3.2 a variant under monitoring |
| March 2025 | Variant begins spreading to other countries including Mozambique |
| June 27, 2025 | First US detection via CDC Traveler-Based Genomic Surveillance |
| September 2025 | Detections begin rising |
| November 2025 – January 2026 | Reaches 30% of sequences in Denmark, Germany, Netherlands |
| January 5, 2026 | First US clinical specimen documented |
| February 11, 2026 | Reported in at least 23 countries; US prevalence 0.19% |
| March 2026 | Surge in Irish Cicada cases reported |
The pattern shows a variant that spread relatively slowly after identification but has gained significant traction in parts of Europe while remaining low in US surveillance.
What health authorities confirm
- Core symptoms match prior variants per HSE/NHS guidance
- Presence in Ireland confirmed with surge in March 2026
- BA.3.2 detected in at least 23 countries globally
- No evidence BA.3.2 causes more severe disease than recent strains
- BA.3.2 is considered to pose a “low additional public health risk” (GAVI)
- Symptoms improve within 3–7 days; full recovery in 1–2 weeks
What remains unclear
- Exact level of vaccine effectiveness against BA.3.2 infection
- Long-term severity and complication rates for this specific variant
- Whether BA.3.2 will become the dominant strain globally
What experts say
“BA.3.2 exhibits antibody escape characteristics, likely driven by mutations in the viral spike protein. Immune escape may increase the likelihood of infection or reinfection but does not imply reduced protection against severe disease.”
“The Cicada variant does not cause new or unusual symptoms compared to other Omicron COVID-19 variants. There is no evidence that BA.3.2 causes more severe disease than recent strains.”
— Stony Brook Medicine
For people in Ireland and elsewhere, the Cicada variant is worth noting but not panicking about. The symptoms are familiar, the recovery timeline is predictable, and health authorities describe the public health risk as low. The practical takeaway is straightforward: if you feel unwell and suspect COVID, test to confirm — and if you test positive, isolate appropriately while monitoring your symptoms. For those around vulnerable individuals, extra caution with masking and testing makes sense given the variant’s immune escape characteristics.
Related reading: How Long Does Gastroenteritis Last – Duration, Symptoms & Recovery
Cicada, designated BA.3.2 and first identified in South Africa, presents familiar symptoms like sore throat and fatigue, as seen in BA.3.2 strain symptomsBA.3.2 strain symptoms{/link> worldwide.
Frequently asked questions
What days of COVID are the worst?
Most people experience the worst symptoms around days 2-4 after symptom onset. After that, improvement is usually gradual but steady for otherwise healthy individuals.
What helps COVID go away faster?
Rest, hydration, and over-the-counter symptom management (like acetaminophen for fever) remain the mainstays. Starting antiviral treatment within 5 days of symptom onset — if you’re eligible — can reduce severity and duration.
Do I still have to isolate if I test positive for COVID?
Current guidance from most health authorities recommends isolating for at least 5 days after symptom onset, with masking for 10 days as a precaution. Exact rules vary by country and individual circumstances.
Is the new variant of COVID serious?
Health authorities including GAVI describe BA.3.2 as posing a “low additional public health risk.” There is no evidence it causes more severe disease than recent strains.
Should we be worried about the current COVID-19 variants?
The Cicada variant warrants attention but not alarm. Staying up to date with vaccines, testing when symptomatic, and isolating appropriately remain the practical steps that matter most.